申请人:Sankyo Company, Limited
公开号:US05260447A1
公开(公告)日:1993-11-09
5-Amino-1-(hydroxymethyl)cyclopentane-1,2,3,4-tetraol and 2-amino-4-(hydroxymethyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]oxazole-4,5, 6-triol, which have the ability to inhibit the activity of sugar hydrolases, especially .beta.-glucosidase and sucrase and can thus be used for the treatment and prophylaxis of tumorous conditions, AIDS, diabetes and obesity, can be prepared by hydrolysis of trehazolin. 2-Amino-4-(hydroxymethyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]oxazole-4,5, 6-triol can also be prepared by fermentation using newly isolated strains Micromonospora sp. SANK 62390, FERM BP-3521 and Amycolatopsis sp. SANK 60791, FERM BP-3513.
5-氨基-1-(羟甲基)环戊烷-1,2,3,4-四醇和2-氨基-4-(羟甲基)-3a,5,6,6a-四氢-4H-环戊基[d]噁唑-4,5,6-三醇具有抑制糖水解酶活性的能力,特别是β-葡萄糖苷酶和蔗糖酶,因此可用于治疗和预防肿瘤病、艾滋病、糖尿病和肥胖症,可通过对特利霉素的水解制备。2-氨基-4-(羟甲基)-3a,5,6,6a-四氢-4H-环戊基[d]噁唑-4,5,6-三醇也可以通过使用新分离的菌株微单孢菌sp.SANK 62390、FERM BP-3521和链霉菌sp.SANK 60791、FERM BP-3513进行发酵制备。